Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Research programme: antioxidant inflammation modulators - Biogen

Next Previous
X
Search
Drug Profile

Research programme: antioxidant inflammation modulators - Biogen

Alternative Names: AIMs - Biogen; CDDO-Im; Nrf2 activators - Biogen; RTA 403; RTA 404; RTA dh404; RTA-411; Synthetic triterpenoids - Biogen; TBEs - Biogen/Abbott; Tricyclic bis-enones - Biogen

Latest Information Update: 27 Sep 2023

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Dartmouth College; University of Texas M. D. Anderson Cancer Center
  • Developer Biogen
  • Class 3-ring heterocyclic compounds; Anti-inflammatories; Antineoplastics; Ketones; Neuroprotectants; Triterpenes
  • Mechanism of Action NF-E2-related factor 2 stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • No development reported Autoimmune disorders; Brain disorders; Cancer; Chronic obstructive pulmonary disease

Most Recent Events

  • 26 Sep 2023 Reata Pharmaceuticals has been acquired and merged into Biogen
  • 28 Oct 2021 No recent reports of development identified for preclinical development in Autoimmune-disorders in USA (PO)
  • 28 Oct 2021 No recent reports of development identified for preclinical development in Brain-disorders in USA

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top